Thomas H. Lee Partners

Here's our weekly roundup of hires and promotions in the alternative investment industry, including moves at Advent International, Northern Trust, Mercer and more.

The following is a snapshot of global private market deal activity for the week of May 20 Divided by asset class, Alternatives Watch tracked a total of $7 billion in deals publicly announced in the five-day period. Private equity: $1.5 billion L ...

New York law firm Ropes & Gray announced that it signed 52 private equity-backed deals last quarter, with valuations of roughly $33 billion as dealmaking picked up at the beginning of 2022. David Blittner, co-chair of Ropes & Gray's private ...

The $66 billion Teachers’ Retirement System of the State of Illinois (TRS) allocated over $1 billion in fresh capital across multiple alternative asset classes as Governor JB Pritzker announced plans to appropriate more money than required to Illinois public pensions ...

Boston-based Thomas H. Lee Partners held the final close for its ninth flagship fund, Thomas H. Lee Equity Fund IX, at its hard cap of $5.6 billion. Fund IX is a continuation of THL’s strategy of investing in Identified Sector ...

The Teachers’ Retirement System of Illinois hired over two dozen managers across the alternative investment spectrum this past month, adding $3.5 billion to private equity, real assets, income and diversifying strategies asset classes. TRS Illinois Executive Director and CIO Stan ...

Boston-based Thomas H. Lee Partners announced the closure of what it calls an "innovative" secondary transaction as an investor in wealth management firm Hightower. The transaction, officials said, provides both new and follow-on capital to optimize Hightower’s value creation potential ...

The Boston-based private equity firm Thomas H. Lee Partners announced the final close of its THL Automation Fund at $900 million. The fund backs automation companies across technology product, software and services businesses that enhance productivity across a range of ...

Private equity platform TPG Capital formed Ellodi Pharmaceuticals, a new specialty pharma company dedicated to the treatment of a chronic, allergic inflammatory disease of the esophagus. The disease, eosinophilic esophagitis (EoE), is rare and effects only 57 out of 100,000 ...